JP2015143248A5 - - Google Patents

Download PDF

Info

Publication number: JP2015143248A5
Authority: JP; Japan
Prior art keywords: unit dose; dha; pharmaceutical composition; composition; fatty acid
Prior art date: 2015-03-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP2015057637A

Other languages

English (en)

Japanese (ja)

Other versions

JP2015143248A (ja

Filing date

2015-03-20

Publication date

2015-12-24

2015-03-20 Application filed filed Critical

2015-08-06 Publication of JP2015143248A publication Critical patent/JP2015143248A/ja

2015-12-24 Publication of JP2015143248A5 publication Critical patent/JP2015143248A5/ja

Status Pending legal-status Critical Current

Links

MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims 26
235000020669 docosahexaenoic acid Nutrition 0.000 claims 15
229940090949 docosahexaenoic acid Drugs 0.000 claims 14
239000008194 pharmaceutical composition Substances 0.000 claims 11
235000014113 dietary fatty acids Nutrition 0.000 claims 10
229930195729 fatty acid Natural products 0.000 claims 10
239000000194 fatty acid Substances 0.000 claims 10
150000004665 fatty acids Chemical class 0.000 claims 10
239000000203 mixture Substances 0.000 claims 10
YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 claims 8
235000021294 Docosapentaenoic acid Nutrition 0.000 claims 4
YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims 4
ITNKVODZACVXDS-YNUSHXQLSA-N ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate Chemical compound CCOC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC ITNKVODZACVXDS-YNUSHXQLSA-N 0.000 claims 3
-1 DHA ester Chemical class 0.000 claims 2
JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims 2
235000021342 arachidonic acid Nutrition 0.000 claims 2
229940114079 arachidonic acid Drugs 0.000 claims 2
235000020673 eicosapentaenoic acid Nutrition 0.000 claims 2
229960005135 eicosapentaenoic acid Drugs 0.000 claims 2
JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims 2
DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 claims 1
GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 claims 1
206010012289 Dementia Diseases 0.000 claims 1
229940121710 HMGCoA reductase inhibitor Drugs 0.000 claims 1
QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 claims 1
230000007000 age related cognitive decline Effects 0.000 claims 1
125000005907 alkyl ester group Chemical group 0.000 claims 1
208000010877 cognitive disease Diseases 0.000 claims 1
KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 claims 1
VCDLWFYODNTQOT-UHFFFAOYSA-N docosahexaenoic acid methyl ester Natural products CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OC VCDLWFYODNTQOT-UHFFFAOYSA-N 0.000 claims 1
239000002552 dosage form Substances 0.000 claims 1
239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 claims 1
208000027061 mild cognitive impairment Diseases 0.000 claims 1

JP2015057637A 2009-02-02 2015-03-20 認知機能改善および心拍数低下のための方法 Pending JP2015143248A (ja)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US14931009P	2009-02-02	2009-02-02
US61/149,310		2009-02-02
US18354809P	2009-06-02	2009-06-02
US61/183,548		2009-06-02

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2011548414A Division JP2012516852A (ja)	2009-02-02	2010-02-02	認知機能改善および心拍数低下のための方法

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2018073345A Division JP2018104477A (ja)	2009-02-02	2018-04-05	認知機能改善および心拍数低下のための方法

Publications (2)

Publication Number	Publication Date
JP2015143248A JP2015143248A (ja)	2015-08-06
JP2015143248A5 true JP2015143248A5 (2)	2015-12-24

Family

ID=42041547

Family Applications (5)

Application Number	Title	Priority Date	Filing Date
JP2011548414A Withdrawn JP2012516852A (ja)	2009-02-02	2010-02-02	認知機能改善および心拍数低下のための方法
JP2015057637A Pending JP2015143248A (ja)	2009-02-02	2015-03-20	認知機能改善および心拍数低下のための方法
JP2018073345A Pending JP2018104477A (ja)	2009-02-02	2018-04-05	認知機能改善および心拍数低下のための方法
JP2019238726A Pending JP2020050675A (ja)	2009-02-02	2019-12-27	認知機能改善および心拍数低下のための方法
JP2022023007A Withdrawn JP2022059063A (ja)	2009-02-02	2022-02-17	認知機能改善および心拍数低下のための方法

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
JP2011548414A Withdrawn JP2012516852A (ja)	2009-02-02	2010-02-02	認知機能改善および心拍数低下のための方法

Family Applications After (3)

Application Number	Title	Priority Date	Filing Date
JP2018073345A Pending JP2018104477A (ja)	2009-02-02	2018-04-05	認知機能改善および心拍数低下のための方法
JP2019238726A Pending JP2020050675A (ja)	2009-02-02	2019-12-27	認知機能改善および心拍数低下のための方法
JP2022023007A Withdrawn JP2022059063A (ja)	2009-02-02	2022-02-17	認知機能改善および心拍数低下のための方法

Country Status (8)

Country	Link
US (2)	US20100203123A1 (2)
EP (2)	EP2939671A1 (2)
JP (5)	JP2012516852A (2)
CN (3)	CN108324706A (2)
AU (2)	AU2016201382A1 (2)
CA (1)	CA2751275A1 (2)
HK (1)	HK1202243A1 (2)
WO (1)	WO2010088700A1 (2)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8207363B2 (en)	2009-03-19	2012-06-26	Martek Biosciences Corporation	Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
WO2011006144A1 (en) *	2009-07-10	2011-01-13	Martek Biosciences Corporation	Methods of treating and preventing neurological disorders using docosahexaenoic acid
CA2833219A1 (en)	2011-05-19	2012-11-22	The Regents Of The University Of California	Nutraceutical composition comprising fisetin and docosahexaenotic acid useful in the treatment of cognitive decline
US20130084272A1 (en) *	2011-09-29	2013-04-04	Philippe Perrin	Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols
US8168611B1 (en)	2011-09-29	2012-05-01	Chemo S.A. France	Compositions, kits and methods for nutrition supplementation
HK1213740A1 (zh) *	2013-03-15	2016-07-15	Inspyr Therapeutics, Inc.	制备抗癌症组合物的方法
FI3626806T3 (fi)	2013-12-20	2024-08-22	Mara Renewables Corp	Menetelmiä öljyn talteenottamiseksi mikro-organismeista
TR201503136A2 (tr) *	2015-03-16	2016-09-21	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	Dronedaron ve esansiyel yağ asitlerinin farmasötik kompozisyonları.
US10851395B2 (en)	2016-06-10	2020-12-01	MARA Renewables Corporation	Method of making lipids with improved cold flow properties
EP3559206B1 (en)	2016-12-22	2025-12-03	Mara Renewables Corporation	Methods for producing biomass rich in dha, palmitic acid and protein using a eukaryotic microorganism
JP7101087B2 (ja) *	2018-09-05	2022-07-14	株式会社伊藤園	軽度認知障害に対する緑茶成分の有効性評価方法
FR3092968B1 (fr) *	2019-02-22	2021-05-21	Microphyt	Complement alimentaire
AU2020325063B2 (en) *	2019-08-08	2026-04-02	Swinburne University Of Technology	Uses of long-chain polyunsaturated fatty acids
MX2022012322A (es)	2020-04-03	2022-11-10	Mara Renewables Corp	Aceites microbianos con niveles altos de ácidos grasos omega-3.
DE102020115238A1 (de) *	2020-06-09	2021-12-09	Pm-International Ag	Nahrungsergänzungsmittel und Nahrungsmittel
CN115867980A (zh) *	2020-07-02	2023-03-28	派尔疗法美国股份有限公司	用于生成和施用数字治疗安慰剂和伪物的系统、方法和设备
CA3204546A1 (en) *	2021-01-15	2022-07-21	Cambridge Cognition Limited	Methods and systems of identifying individuals for perioperative neurocognitive disorder and/or post-viral cognitive impairment
WO2024155781A1 (en) *	2023-01-18	2024-07-25	Bioventures, Llc	Method of preventing and treating alzheimer's disease and related dementias with drugs inhibiting the interaction between 14-3-3g protein and hexokinase-1 protein
WO2025100476A1 (ja) *	2023-11-10	2025-05-15	国立大学法人京都大学	生理機能改善用の組成物
JP2025079778A (ja) *	2023-11-10	2025-05-22	ダイドーグループホールディングス株式会社	生理機能改善用の組成物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5407957A (en)	1990-02-13	1995-04-18	Martek Corporation	Production of docosahexaenoic acid by dinoflagellates
US20050027004A1 (en) *	1993-06-09	2005-02-03	Martek Biosciences Corporation	Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
PT707487E (pt) *	1993-06-09	2004-08-31	Martek Biosciences Corp	Metodos e composicoes farmaceuticas uteis no tratamento de disturbios neurologicos
EP0776356B1 (de)	1994-08-16	1999-06-30	Dr. Frische GmbH	Verfahren zur gewinnung von nicht wasserlöslichen, nativen produkten aus nativen stoffgemengen mit hilfe der zentrifugalkraft
US6582941B1 (en) *	1995-04-17	2003-06-24	Japan As Represented By Director-General Of Agency Of Industrial Science And Technology	Microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fatty acids by using the microorganisms
JP3985035B2 (ja) *	1995-09-14	2007-10-03	独立行政法人産業技術総合研究所	（ｎ−６）系ドコサペンタエン酸含有油脂ならびに該油脂の製造方法および用途
DE60012934T2 (de)	1999-02-26	2005-08-25	Martek Biosciences Corp.	Verfahren zum Abtrennen von einem Docosahexaensäure enthaltenden Triglycerid aus einem Triglyceridgemisch
AU2001232786A1 (en)	2000-01-11	2001-07-24	Monsanto Company	Process for making an enriched mixture of polyunsaturated fatty acid esters
CA2397655C (en)	2000-01-19	2012-06-05	Craig M. Ruecker	Solventless extraction process
AU2001258705A1 (en)	2000-04-12	2001-10-23	Westfalia Separator Industry Gmbh	Method for the fractionation of oil and polar lipid-containing native raw materials using alcohol and centrifugation
EP1392623A4 (en)	2001-05-14	2005-05-04	Martek Biosciences Corp	PREPARATION AND USE OF A POLAR LIPID RICH FRACTION CONTAINING HIGHLY UNSATURATED OMEGA-3 AND / OR OMEGA-6 FATTY ACIDS FROM MICROBES, SEEDS OF GENETICALLY MODIFIED PLANTS AND MARINE ORGANISMS
JP4728561B2 (ja)	2001-05-14	2011-07-20	マーテックバイオサイエンシーズコーポレーション	植物種子および微生物由来のステアリドン酸およびγ−リノレン酸を含む極性脂質リッチ画分の精製および使用方法
AU2002320251A1 (en) *	2001-07-05	2003-01-21	Vital Basics, Inc.	Compositions for improving mental performance
US9101151B2 (en)	2002-05-03	2015-08-11	Dsm Ip Assets B.V.	High-quality lipids produced by enzymatic liberation from biomass
WO2006077495A1 (en) *	2005-01-24	2006-07-27	Pronova Biocare As	Use of a fatty acid composition containing dha for the production of a medical product or a food stuff for the treatment of amyloidos-rerelated diseases
US8324276B2 (en) *	2005-01-24	2012-12-04	Pronova Biopharma Norge As	Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
WO2006116755A2 (en) *	2005-04-28	2006-11-02	Trustees Of Tufts College	Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function
BRPI0613303A8 (pt) *	2005-05-23	2018-01-30	Massachusetts Inst Technology	composições que contêm pufa e/ou uridina e métodos de uso das mesmas
BRPI0613358A8 (pt) *	2005-07-08	2017-12-26	Dsm Ip Assets Bv	ácidos de gordura poli - insaturada para o tratamento da demência e condições relacionadas à pré-demência
WO2009002145A1 (en) *	2007-06-26	2008-12-31	N.V. Nutricia	Lipid composition for improving function of brain functioning
AU2008269989B2 (en)	2007-06-29	2014-02-27	Dsm Ip Assets B.V.	Production and purification of esters of polyunsaturated fatty acids
WO2011006144A1 (en) *	2009-07-10	2011-01-13	Martek Biosciences Corporation	Methods of treating and preventing neurological disorders using docosahexaenoic acid

2010
- 2010-02-02 WO PCT/US2010/022952 patent/WO2010088700A1/en not_active Ceased
- 2010-02-02 CA CA2751275A patent/CA2751275A1/en not_active Abandoned
- 2010-02-02 CN CN201810349154.XA patent/CN108324706A/zh active Pending
- 2010-02-02 CN CN2010800157224A patent/CN102365087A/zh active Pending
- 2010-02-02 EP EP15162676.9A patent/EP2939671A1/en not_active Withdrawn
- 2010-02-02 US US12/699,009 patent/US20100203123A1/en not_active Abandoned
- 2010-02-02 JP JP2011548414A patent/JP2012516852A/ja not_active Withdrawn
- 2010-02-02 CN CN201410152946.XA patent/CN104042600A/zh active Pending
- 2010-02-02 EP EP10703592A patent/EP2391361A1/en not_active Withdrawn
2012
- 2012-12-13 US US13/713,980 patent/US20130172412A1/en not_active Abandoned
2015
- 2015-03-17 HK HK15102730.4A patent/HK1202243A1/xx unknown
- 2015-03-20 JP JP2015057637A patent/JP2015143248A/ja active Pending
2016
- 2016-03-03 AU AU2016201382A patent/AU2016201382A1/en not_active Abandoned
2017
- 2017-10-10 AU AU2017245327A patent/AU2017245327A1/en not_active Abandoned
2018
- 2018-04-05 JP JP2018073345A patent/JP2018104477A/ja active Pending
2019
- 2019-12-27 JP JP2019238726A patent/JP2020050675A/ja active Pending
2022
- 2022-02-17 JP JP2022023007A patent/JP2022059063A/ja not_active Withdrawn

Publication	Publication Date	Title
JP2015143248A5 (2)	2015-12-24
HRP20210686T1 (hr)	2021-06-11	Pripravci i postupci za liječenje moždanog udara kod subjekta na istodobnoj terapiji statinom
JP2015503590A5 (2)	2016-03-17
JP2013521310A5 (2)	2014-04-17
RU2020123679A (ru)	2022-01-17	Композиции и способы лечения и/или предотвращения сердечно-сосудистого заболевания
JP2019048843A5 (2)	2022-02-17
JP2016511753A5 (2)	2017-02-23
HK1204272A1 (en)	2015-11-13	Methods of treating pediatric metabolic syndrome
EP4338805A3 (en)	2024-05-22	Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
IN2014DN06125A (2)	2015-08-14
NZ618734A (en)	2015-01-30	Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
NZ727980A (en)	2018-08-31	Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
JP2015520235A5 (2)	2016-08-04
RU2018111327A (ru)	2019-10-04	Способ ингибирования всасывания и/или повышения выведения липидов с использованием d-псикозы
JP2016501248A5 (2)	2017-01-26
RU2018136872A (ru)	2018-11-27	Композиции, содержащие 15-oh эпк, и способы их применения
RU2013146517A (ru)	2015-04-27	Композиции и способы, пригодные для облегчения возрастных заболеваний
JP2015038135A5 (2)	2015-04-09
JP2014515011A5 (2)	2015-04-30
JP2016510326A5 (2)	2017-02-23
JP2014512351A5 (2)	2015-05-14
RU2016129079A (ru)	2018-01-24	Композиции омега-3 жирных кислот для лечения заболеваний, вызывающих поражение нервной системы
JP2016053065A5 (2)	2016-06-02
WO2017077528A3 (en)	2017-08-03	Methods and pharmaceutical compositions for treatment of lung inflammation
JP2013507454A5 (2)	2013-12-19